- CATX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Perspective Therapeutics (CATX) 10-K/A2012 FY Annual report (amended)
Filed: 26 Oct 12, 12:00am
Exhibit 32
Section 1350 Certifications
Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of IsoRay, Inc., a Minnesota corporation (the Company), hereby certify that:
To my knowledge, the Annual Report on Form 10-K/A of the Company for the annual period ended June 30, 2012 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 25, 2012
/s/ Dwight Babcock
Dwight Babcock
Chief Executive Officer
(Principal Executive Officer)
Dated: October 25, 2012
/s/ Brien L. Ragle
Brien l. Ragle
Controller
(Principal Financial and Accounting Officer)